Training scientists to combat emerging viral diseases in West Africa
Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN)
This study is all about helping communities in West Africa better handle viral diseases like chikungunya and Ebola by training local scientists to predict and prevent outbreaks, so everyone can stay healthier and safer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-11040348 on NIH RePORTER |
What this research studies
This research focuses on understanding and addressing the threat of emerging viral diseases, particularly arboviruses like chikungunya and Ebola, which pose significant health risks in West Africa. The project aims to train a new generation of scientists in the region to predict, prevent, and manage outbreaks through a multidisciplinary approach that combines scientific research and public health strategies. By leveraging existing research centers and expertise, the initiative seeks to enhance local capabilities in dealing with these infectious diseases and their impact on communities.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals living in West Africa who are at risk of exposure to arboviruses or zoonotic diseases.
Not a fit: Patients who are not located in West Africa or who do not have a risk of exposure to the targeted viral diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the ability to predict and control outbreaks of dangerous viral diseases in West Africa, ultimately saving lives.
How similar studies have performed: Other research initiatives targeting emerging infectious diseases in similar regions have shown promise in improving outbreak response and public health outcomes.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Weaver, Scott C — University of Texas Med Br Galveston
- Study coordinator: Weaver, Scott C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.